Janus Henderson Group’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15.2M | Sell |
|
|||||
|
2025
Q2 | $6.51M | Sell |
|
|||||
|
2025
Q1 | $6.87M | Sell |
|
|||||
|
2024
Q4 | $12.5M | Sell |
|
|||||
|
2024
Q3 | $33.9M | Sell |
|
|||||
|
2024
Q2 | $67.1M | Sell |
|
|||||
|
2024
Q1 | $102M | Buy |
|
|||||
|
2023
Q4 | $62.7M | Buy |
|
|||||
|
2023
Q3 | $35M | Sell |
|
|||||
|
2023
Q2 | $51.3M | Buy |
|
|||||
|
2023
Q1 | $32.3M | Buy |
|
|||||
|
2022
Q4 | $32.6M | Sell |
|
|||||
|
2022
Q3 | $21.2M | Buy |
|
|||||
|
2022
Q2 | $9.32M | Sell |
|
|||||
|
2022
Q1 | $25.2M | Buy |
|
|||||
|
2021
Q4 | $36.2M | Buy |
|
|||||
|
2021
Q3 | $41M | Sell |
|
|||||
|
2021
Q2 | $37.1M | Buy |
|
|||||
|
2021
Q1 | $50.7M | Buy |
|
|||||
|
2020
Q4 | $39.9M | Buy |
|